Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shortened antibiotic therapy for febrile urinary tract infections in children
2019-001941-41Phase 4Completed
- Sponsor
- IRCCS Burlo Garofolo
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of amoxicillin + clavulanate in urinary tract infection (UTI) and acute pyelonephritis (2 arms), sponsored by IRCCS Burlo Garofolo. Primary endpoint: Rate of infection recurrence after discontinuation of antibiotic therapy. Started May 2021; status: completed.
02
Drugs
amoxicillin + clavulanate
03
Conditions
urinary tract infection (UTI)acute pyelonephritis
Beyond the preview
Go deeper on 2019-001941-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001941-41.